Aiko Yamaguchi

6PUBLICATIONS
35CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 18, 2026
Glycoprotein mucin 13 expression as a theranostic target in colorectal cancer.

|Aug 25, 2025
Preclinical Fluorescence-Guided Imaging Leveraging Surrounding Sentinel Tumor Microenvironment Identifies High-Risk Premalignant Pancreatic Lesions.

Shilpa Sharma, Xiaoxia Wen, Jianbo Wang

|Mar 07, 2025
177Lu-Labeled Antibody-Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors.

Aiko Yamaguchi, Chisato M Yamazaki, Yasuaki Anami

|Apr 15, 2022
Homogeneous antibody-angiopep 2 conjugates for effective brain targeting.

Yasuaki Anami, Wei Xiong, Aiko Yamaguchi

|Dec 23, 2021
Reduced Fatty Acid Use from CD36 Deficiency Deteriorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice.

Yogi Umbarawan, Ryo Kawakami, Mas Rizky A A Syamsunarno

|Jun 11, 2021
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance.

Chisato M Yamazaki, Aiko Yamaguchi, Yasuaki Anami

Pageof 1

Frequent Collaborators

3 joint publications

Chisato M Yamazaki

3 joint publications

Yasuaki Anami

3 joint publications

Ningyan Zhang

3 joint publications

Zhiqiang An